Related to Belgian Tech-Transfer Organization Gets Additional €16M from K.U. Leuven and EIF

• Cara Raises $15M in Series D Fundraising for Phase II Development of Pain Relief Drug
  
• Cerenis Raises €40M in Series C and Wins €10.7M from French Government
  
• TPP and Edinburgh University Team Up to Develop Preclinical IP for Multiple Diseases
  
• Pfizer Inks Deal with K.U. Leuven for HIV Drugs with New Mechanism of Action
  
• Aerie Raises $30M to Progress Glaucoma Drug into Phase III
  
• Allergy Therapeutics Firm Anergis Raises $20M in Series A Fundraising
  
• Supreme Court Rules Against Stanford in Patent Dispute with Roche over HIV Test
  
• Ambit Scores $30M to Advance Kinase Inhibitor Pipeline
  
• GSK, Lilly Venture Funds Join in Nimbus Discovery’s $24M Series A Financing Round
  
• Biopharma Investment Grows During Q4 but VCs Fund Fewer Early Deals
  
• Growth of Corporate Ventures Reflected in Rising VC Numbers
  
• Biogen Idec Explains Company’s Move Away from Venture Funding
  
• UPenn Cancer Institute's Suit Against Ex-Director Reflects Greater Focus on IP Protection
  
• Russian Tech Fund Joins U.S. VC Firm in $760M Biopharma Venture
  
• Index Ventures Launches €150M Life Sciences Fund with GSK, J&J
  
• Merck & Co. Joins VC Firms to Initiate R&D Fund in Quebec
  
• GEN Poll Respondents ‘Somewhat’ Optimistic VC Market Will Improve This Year
  
• Poll Respondents Divided on Impact of FDA Legislation on Investing Environment
  
• Eli Lilly Invests C$40M in C$150M Early-Stage Drug Development Fund
  
• GSK, Canadian Center Launch Funds to Bolster Commercialization of Research